Latest Breaking News On - Greg korbutt - Page 1 : comparemela.com

Research offers new hope to diabetes patients • Troy Media

Gillian Rutherford • Promising results in innovative diabetes treatment method that enhances the safety of insulin cell transplants

Gregory korbuttGreg korbuttPurushothaman kuppanGillian rutherfordCanada researchUniversity of albertaCanadian institutes of health researchUniversity of alberta folioTroy mediaAndrew pepperCanadian institutesCanada research chairCell therapiesAlberta cell therapy manufacturingEdmonton protocolTroy media editorial content provider

Biomanufacturing partnership boosts Canada s life-saving treatment and vaccine capacity

Biomanufacturing partnership boosts Canada s life-saving treatment and vaccine capacity
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Greg korbuttDuncan stewartCarla sojonkyJohn lewisUniversity of albertaProstate cancer researchCancer research institute of northern albertaEntos pharmaceuticalsOttawa hospital biotherapeutics manufacturing centreUniversity of ottawaCanada foundation for innovationAlberta cell therapy manufacturingOttawa hospitalCarla sojonky chairCancer research instituteNorthern alberta

University of Alberta: Biomanufacturing partnership boosts Canada s life-saving treatment and vaccine capacity – India Education | Latest Education News | Global Educational News

University of Alberta: Biomanufacturing partnership boosts Canada s life-saving treatment and vaccine capacity – India Education | Latest Education News | Global Educational News
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

Made-in-Alberta COVID-19 vaccine candidate goes to clinical trials

Date Time Made-in-Alberta COVID-19 vaccine candidate goes to clinical trials A made-in-Alberta COVID-19 vaccine is taking a major step forward on the path to Health Canada approval with the start of a Phase 1 clinical trial. Entos Pharmaceuticals, an Edmonton company led by CEO and University of Alberta researcher John Lewis, has shipped a vaccine for testing to the Canadian Centre for Vaccinology in Halifax. The clinical trial will test the safety of the DNA-based vaccine in 72 participants, split between young adults and older Canadians, with the aim of moving into a larger Phase 2 trial testing efficacy of the vaccine by late spring.

South africaSouth africanGreg korbuttGayle piatJohn lewisUniversity of albertaEntos pharmaceuticalsHealth canadaCanadian centre for vaccinologyCanadian institutes of health researchCanadian centreAlberta cell therapy manufacturingNational research councilCanada industrial research assistance programCanadian institutesVaccine development

COVID-19 vaccine developed at University of Alberta proceeding to clinical trials

EDMONTON An Alberta-developed COVID-19 vaccine using new technology is one step closer to starting clinical trials. John Lewis, University of Alberta professor and CEO of Entos Pharmaceuticals, has shipped a vaccine for further testing to the Canadian Centre for Vaccinology in Halifax – a step forward toward its Health Canada approval. The made-in-Alberta COVID-19 vaccine will commence its Health Canada Phase 1 human clinical trial with the aim of moving it to a larger Phase 2 trial by late spring to test its efficacy. “Its been a long road,” Lewis said in an interview with CTV News Edmonton. “I am definitely enthusiastic about where it is going from here.”

Greg korbuttJohn lewisUniversity of albertaEntos pharmaceuticalsHealth canada phaseHealth canadaCanadian centre for vaccinologyCanadian centreAlberta cell therapy manufacturing facilityEdmonton newsRed deerGrande prairieFort mcmurraySt albertSherwood parkSpruce grove